Advaxis Inc. buy melinda
Start price
06.02.17
/
50%
€126.51
Target price
19.06.17
€135.30
Performance (%)
-34.65%
End price
19.06.17
€82.67
Summary
This prediction ended on 19.06.17 with a price of €82.67. The BUY prediction by melinda for Advaxis Inc. performed very badly with a performance of -34.65%. melinda has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Advaxis Inc. | - | - | - | - |
iShares Core DAX® | -1.958% | 4.037% | 23.702% | 22.534% |
iShares Nasdaq 100 | 0.272% | 8.670% | 28.181% | 41.859% |
iShares Nikkei 225® | 0.377% | 7.232% | 21.118% | 9.739% |
iShares S&P 500 | 0.370% | 6.511% | 29.221% | 41.850% |
Comments by melinda for this prediction
In the thread Advaxis Inc. diskutieren
Gebärmutterhalskrebs
6. Februar 2017 Advaxis kündigt die erste Patientenbehandlung in der globalen Phase - 3 - Studie für AIM2CERV hohes Risiko, lokal fortgeschrittenem Gebärmutterhalskrebs
(Vom Mitglied beendet)